&#xa0;
defaultWritten evidence submitted by the defaultSociety for General Microbiology (RaD0007)default&#xa0;
defaultWe are pleased to respond to the 
defaultHouse of 
defaultCommons
default 
defaultSelect Committee on Science and Technology – 
defaultResearch and Development funding for science and technology in the UK
default.
default&#xa0;
defaultThe National Audit Office (NAO) memorandum on R&amp;D funding is excellent, and we thank the Committee
default, and the NAO, for producing it.
default&#xa0;
defaultWe hav
defaulte divided our response into 
defaultfive
default 
defaultsections: 
default(1) key 
defaultpoints
default; 
default(
default2
default) the Society for General Microbiology
default and its role in UK microbiology
default;
default 
default(3) overview of microbiology R&amp;D; 
default(
default4
default) 
defaultthe UK’s R&amp;D landscape in microbiology;
default 
defaultand 
default(
default5
default) 
defaults
defaultuggestions for future inquiries on 
defaultUK R&amp;D funding
default.
default&#xa0;
defaultWe hope this information is useful to 
defaultyou as you work on your review.
default 
defaultWith our national reach, and deep knowledge of our d
defaultiscipline, we can provide 
defaultfurther information
default as needed
default.
default&#xa0;
default1.default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultKey pointsdefault&#xa0;
default2.default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultAbout the Society for General defaultMicrobiologydefaultThe Society for General Microbiology (SGM) is a membership organisation for scientists who work in all areas of microbiology. It is the largest learned microbiological society in Europe with a worldwide membership based in universities, indust
defaultry, hospitals, research institutes and schools. The SGM publishes key academic journals in microbiology and virology, organises international scientific conferences and provides an international forum for communication among microbiologists and supports th
defaulteir professional development. The Society promotes the understanding of microbiology to a diverse range of stakeholders, including policy-makers, students, teachers, journalists and the wider public, through a comprehensive framework of communication activ
defaultities and resources.
default 
defaultFurther information about SGM is provided in Appendix 1.
default&#xa0;
default3.default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultOdefaultverview of microbiology R&amp;Ddefault4.default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultThe UK’s R&amp;D landscape in microbiologydefault default4.1.default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultMicrobiology’s 
defaultUK-wide 
defaultreach
default 
defaultMicrobiological 
defaultresearch is UK-wide.
default 
defaultThe Google Map 
defaulton the left
default gives a 
defaultsnapshot
default of 
defaultwhere 
defaultm
defaulticrobiology research 
defaultoccurs 
default(r
defaulted is for universities, 
defaultgreen
default for public sector 
defaultresearch establishments
default, and 
defaultblue
default for
default 
defaultcompanies
default). T
defaulthe map i
defaults
default 
defaultbest viewed 
defaulton
defaultline
default.
default&#xa0;
defaultUniversities strong in microbiology are distributed throughout the country (see section 4.2). 
defaultLooking at the private sector, 
defaultfirms
default conducting microbiology R&amp;D
default are also found throughout the UK: some are associated with former ICI or Big Pharma sites, such as Billingham in County Durham or Alderley 
defaultEdge
default in Cheshire; others co-locate with universities; others still locate in scienc
defaulte par
defaultks, or strike out on their own.
default&#xa0;
defaultIn July, the Sheffield-based vaccine discovery start-up
default Absynth received £850k funding from 
defaultFusion IP
default, The North West Fund
default (European Union-backed), and the
default Technology Strategy Board
default.
default 
defaultIn the chemicals and fuels sector, large enterprises with microbiology activities are based in 
defaultTeesside
default;
default and microbiology-based 
defaultsmall and medium-sized enterprises (
defaultSMEs
default)
default in Oxford, Guildford, Hertfordshire, Edinburgh, inter alia.  Increasingly
default,
default traditional
default chemical companies (e.g
default.,
default 
defaultINEOS
default at
default 
defaultGrangemouth
default) are becoming interest
defaulted
default in the applications of Synthetic Biology to create “microbiological factories”
default 
default(see section 4.4)
default.
default&#xa0;
defaultThere is a real possibility of 
defaultgrowing 
defaultsignificant research, development, and produc
defaulttion processes across the country, with clear translation of benefits to the economy, environment, and public health.
default&#xa0;
default4.2.default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultM
defaulticrobiology
default’s vitality 
defaultin the universities
defaultWe
default live in
default 
defaultexhilarating
default times
default, in terms of research and innovation
default in microbiology. 
defaultGenomics, the metagenome, the microbiome, microbial ecology, synthetic biology
default, 
defaultindustrial biocatalysis, fermentation technology, biochemical engineering 
defaultand new developments in
default 
defaultbioinformatics, all imply a range of opportunities that have emerged from micr
defaultobiological research
default in universities
default, or 
defaultare 
defaulthaving significant impacts upon 
defaultthe
default productivity and inventiveness
default of university research
default.
default These present opportunities to tackle
default 
defaultwider problems such as climate change, biofuels
default and chemicals
default, food and water secu
defaultrity, infectious disease, 
defaultand 
defaultantibiotic resistance
default.
default&#xa0;
defaultThe universities 
defaulthave particular
default 
defaultstrengths
default for effective R&amp;D
default, notably
default:
default&#xa0;
default4.3.default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultEmerging 
defaultopportunities to
default fight infectious disease
defaultM
defaulticrobiology research
default concerned 
defaultwith 
default‘
defaultanti-infective
defaults
default’
default technology (to detect
default, prevent, and treat 
defaultinfectious disease)
default is an emerging source of private sector innovation
default. 
defaultThere are critical 
defaultdevelopment
defaults across three areas, namely
default (
default1
default) 
defaultantimicrobial drugs aimed at bacterial and fungal 
defaultinfections (particularly vital due to the rise of antibiotic resistance
default in bacteria
default)
default; 
default(
default2
default) 
defaultdiagnostic devices
default; and (
default3
default) vaccines
default.
default Collectively, these measures have the potential to solve infectious disease
defaults, such as 
defaultthose in the
default globally-important
default aged care 
defaultsector (e.g., 
defaulthospital-acquired infections
default)
default, and also represent significant opportunities in the global healthcare
default market
default.
default&#xa0;
defaultThe 
defaultChief Medical Officer
default has drawn attention to the problem of antibiotic resistance. 
defaultWe
default 
defaultwelcome 
defaultwider
default 
defaultg
defaultovernment
default 
defaultmoves
default on this top
defaultic
default, 
defaultsuch as
default recent
default 
defaultinvestments 
defaultmade by
default the Technology Strategy Board 
default(
defaultvia the Biomedical Catalyst
default)
default,
default and
default the Ministry of Defence
default.
default There is significant potential in
default 
defaultan emerging commercial sector: o
defaultur own survey indicates that there are now at least 20
default small
default firms across the 
defaultUK actively
default involved in research 
defaulton antimicrobial resistance
default (see the Microbiology Research Map, online
default)
default.
default These firms deploy a range of different approaches, from 
defaultinvestigation 
defaultof natural products, to development of vaccines, and other m
defaultethods.
default 
defaultDiverse approaches represent a richness of endeavour.
default&#xa0;
defaultBut f
defaulturther commitment is critical 
defaultif we want 
defaulttake-off for 
defaulta wider range of measures including antimicrobial therapies, diagnostic devices, and vaccines (
defaultas is 
defaultsupport for 
defaultskilled
default, 
defaultmotivated, i
defaultmaginat
defaultive and well-trained scientists
default in this field
default)
default.
default 
defaultD
defaultifferent, but complementary, approaches
default 
defaultc
defaultould usefully be 
defaultdriven forward
default 
defaultby
default a
default new
default 
defaultCatalyst Fund 
defaultfocus
defaulted
default on 
defaultAnti
default-infective
defaults
default 
defaultT
defaultechnology
default.
default&#xa0;
default4.4.default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultB
defaultiotechnology in the green economy
default – opportunities, and challenges
defaultIt is estimated that over 30,000 different chemicals are now in commercial use. 
defaultU
defaultnstable oil prices – and emerging green technologies – are prompting a transition
default from oil-based chemistry
default towards alternative, renewable starting materials. 
defaultFirms involved range from the very large
default, 
defaultto SMEs.
default Microbiological research 
defaultplays
default a pivotal role, as the yet-to-be-developed production processes depend on bacteria and fungi to convert sugars into useful
default chemicals.
default&#xa0;
defaultThere are 
defaulttwo
default interrelated aspects to government support 
defaultfor science in this
default 
defaultarea
default. 
defaultThe first concerns research and development to establish viable production processes
default using pre-existing knowledge (
defaultknowledge 
defaulttranslation)
default; good progress is bein
defaultg made here
default. 
defaultThe 
defaultsecond
default concerns basic research on 
defaultthe 
defaultmicrobi
defaultal
default physiology
default 
defaultneeded to 
defaultoperate
default these processes
default on an industrial scale
default; 
defaultin this area
default there is
default significant
default weakness.
default&#xa0;
defaultG
defaultovernment
default support
default 
defaultfor knowledge translation 
defaulthas helped the UK into
default the
default top 
defaultfive
default of 
defaultEU
default countries for commercialisation of research in this 
defaultfield
default.
default 
defaultG
defaultovernment 
defaultrecently expanded its backing
default for applied research
default 
defaultthrough the
default 
defaultBiological Sciences and
default Biotechnology Research Council (BBSRC)/Technology Strategy Board (TSB)-funded Industrial Biotechnology Catalyst
default.
default 
defaultThis scheme, which launches in 2014, should be encouraged.
default 
default&#xa0;
defaultOn the second aspect, however, there appears to be less progress
default. 
defaultOne significan
defaultt scientific issue for R&amp;D expenditure is scaling-up production. When moved to large scale – as is needed for industry – useful end products kill the micro-organisms producing them. Yields are therefore too low. 
defaultW
defaulte are yet to develop an ‘off-the shelf’ ind
defaultustrial biotechnology.
default&#xa0;
defaultAs noted in a policy research paper from NESTA – and widely acknowledged elsewhere – creative solutions will emerge from greater collaboration between chemical engineering 
defaultand
default microbiology.
default 
default&#xa0;
defaultThe Engineering and Physical Sciences R
defaultesearch Council (EPSRC) supports
default relevant
default research but the funding is targeted at the engineering
default side
default. The BBSRC is the major Research Council 
defaultof relevance
default to the microbiological 
defaultside
default; BBSRC funding
default for ‘industrial biotechnology and bioenergy’ amounts to 
default£26.2
defaultm in 2012/13, but this is split between 18 often eclectic areas ranging from tissue engineering to biomass crops.
default The 
defaultfocus
default 
defaultis therefore
default diffuse
default,
default with 
defaultrelatively little opportunity for 
defaultthe 
defaultscientific
default 
defaultcommittees
default that allocate
default research
default 
defaultfunds
default to ma
defaultke 
defaultmajor investment in one area.
default&#xa0;
defaultThere is, as a consequence, a huge funding gap for applied microbiological research in technology readiness levels 1-4 (discovery, research
default,
default and proof of concept)
default for key areas of
default basic science underlying
default industrial biotechno
defaultlogy
default.
default 
default 
defaultThe BBSRC 
defaultNetworks in Industrial Biotechnology and Bioenergy (NIBB)
default 
defaultwill 
defaultusefully 
defaultlink together interested researchers for the purpose of knowledge exchange
default, but 
defaultthey are not
default 
defaulta
default research
default funding mechanism
default.
default 
defaultIt would therefore be worth examin
defaulting
default the 
defaultvalue of a ring-fenced 
defaultfunding
default pathway for synthetic biology, targeted at microbial physiology for 
defaultindustrial application. This could go some way to supply the
default research needed
default in terms of scaling-up production processes.
default&#xa0;
default4.5.default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultThe importance of Public Sector Re
defaultsearch Establishments
default (PRSEs)
defaultWe 
defaultlooked at
default the Chief Scientific Advisor
default (CSO)
default’s recent list of PSREs
default 
defaultto determine where microbiological research 
defaultconcentrates
default.
default 
defaultThe CSO does not make the conventional distinction between ‘PSREs’ (taken to mean institutions d
defaultirectly under a ministerial department), and ‘research institutes’ (government-funded, but held at arm’s length through the Research Councils). 
default&#xa0;
defaultIn our analysis, there
default are a total of about 30 research establishments
default and research institutes
default with significant microbiological interests
default (see map
default;
default detailed
default list available on request from 
defaultthe Society for General Microbiology
default)
default. The majority
default are located in England
default; o
defaultne is 
defaultin
default Northern Ireland
default (not included on the CSO’s list)
default; and two in Scotland
default.
default&#xa0;
defaultT
defaulth
defaulte
defaultse
default institutions
default 
defaultcover the gamut of microbiological research, from the most applied, to 
defaultthe bluest skies;
default 
defaultbut sharing a clear 
defaultfocus on
default 
default(i) 
defaultinfectious disease
default;
default 
defaultand
default (ii) agriculture
default.
default W
defaultith their specialist infrastructures, 
defaultthey 
defaultsupport
default significant research st
defaultrengths in 
defaultUK 
defaultmicrobiology
default, covering vital topics for future public health
default, food production, and the 
defaultagricultural economy
default. The
defaulty
default 
defaultprovid
defaulte
default essential frontline services
default,
default such as p
defaultredicting
default and controlling
default disease
default outbreaks
default.
default 
defaultThey
default 
defaulthave potentially enormous value
default in
default link
defaulting
default basic
default,
default strategic and applied research
default, with a longer time-
defaulthorizon than 
defaultthe shorter-term
default grants 
defaultoffered to universities
default, and acting as nuclei for innovation
default.
default 
defaultDeveloping more effective synergistic relationships
default between researchers in universities
default and public sector research establishments should be a
default 
defaultfuture goal.
default&#xa0;
default5.default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultSuggestions for future inquiries on UK R&amp;D fundingdefault&#xa0;
default&#xa0;
defaultSociety fdefaultor General Microbiology – President default&amp; Chair of the Policy Committee:default&#xa0;
defaultSociety for General defaultMicrobiology – Policy Committee:default&#xa0;
defaultThe Policy Committee 
defaulta
defaultdditionally
default sought the views of
default 
defaultDr Mike Dawson (Novacta Biosystems Ltd.), Professor Laura Piddock (University of Birmingham), 
defaultDr Malcolm Rhodes
default (University of Manchester)
default, 
defaultand Dr Rebecca Wood (Chemical Innovation Knowledge Tr
defaultansfer Network)
default 
defaultin preparing this response.
default 
defaultMr 
defaultJonathan Fuhrmann (Society for General Microbiology) contributed significantly to 
defaultdata gathering and analysis
default.
default&#xa0;
defaultAugust 2013
defaultA world in which the science of microbiology provides maximum benefit to society.
default&#xa0;
defaultTo promote 
defaulthigh-quality microbiological science, both nationally and internationally, to a diverse range of stakeholders.
default&#xa0;
defaultThe potential socio-economic benefits arising from microbiology are substantial. They include:
default&#xa0;
defaultTo achieve its Vision and Mission, the Society will work towards the strategic priorities below.
default&#xa0;
defaultThe Society is a Charity 
defaultregistered in England and Wales (No. 264017) and in Scotland (No.
defaultSC039250) and a Company Limited by Guarantee, registered in England and Wales (No.
default1039582).
default&#xa0;
defaultMarlborough House 
default              
default              
default              
default              
defaultTelephone: 0
default118-988 1829
defaultBasingstoke Road 
default              
default              
default              
default              
defaultFax: 
default0
default118-988 5656
defaultSpencers 
defaultWood 
default              
default              
default              
default              
defaultWeb: www.sgm.ac.uk
defaultReading RG7 1AG, UK
default&#xa0;
default&#xa0;
default National Audit Office, 2013, 
defaultResearch and Development funding for science and technology in the UK
default; 
defaulthttp://www.nao.org.uk/wp-content/uploads/2013/07/Research-and-development-funding-for-science-and-technology-in-the-UK1
default.pdf
default 
defaulthttps://mapsengine.google.com/map/viewer?mid=zwNbpN4FzNro.kexdTsV5eHOY
default 
default 
defaulthttp://www.growingbusiness.co.uk/absynth-biologics-secures-850-000-investment-from-the-north-west-fund-for-biomedical.ht
defaultml
default 
default Based on Society for General Microbiology survey of microbiology papers published in the past decade by researche
defaultrs at the UK’s universities
default.
default Technology Strategy Board/Medical Research Council, 
defaultBiomedical Catalyst (Round 3) Awards
default, undated; 
defaulthttps://www.innovateuk.org/documents/1524978/1866952/Biomedical+Catalyst+-+Round+3+Awards/1743b16c-c324-443c-81c6-ab2672
default136460
default 
default 
defaulthttps://mapsengine.google.com/map/viewer?mid=zwNbpN4FzNro.kexdTsV5eHOY
default 
default 
defaulthttp://www.bbsrc.ac.uk/news/industrial-biotechnology/2013/130125-n-industrial-biotechnology-catalyst.aspx
default; 
defaulthttps://connect.innovateuk.org/web/bbsrc-nibb
default NESTA, 2011, 
defaultFinancing Industrial Biotechnology in the UK,
default p. 54 (recommendation 7); 
defaulthttp:/
default/www.nesta.org.uk/library/documents/FinancingIndBioTechv12.pdf
default Overall figure supplied to SGM by Dr Sharon Fortune (BBSRC). The relative funding allocations 
defaultfor
default th
defaulte 18 topic areas were not given
default.
default 
defaulthttps://www.innovateuk.org/documents/1524978/2139688/High+Value+Manufacturing+Strategy+2012-15/
default, p. 13
default 
defaultDr 
defaultSa
defaultul Purton, 07/03/13 11:54, Establishing the network and putting together an application
default; 
defaulthttps://connect.innovateuk.org/web/bbsrc-nibb/discussions/-/message_boards/message/7062630?p_p_auth=RmXyI7r9
default 
defaulthttp://www.parliament.uk/documents/commons-committees/science-technology/130516walportpsres.pdf
default 
default 
defaulthttps://mapsengine.google.com/map/viewer?mid=zwNbpN4FzNro.kexdTsV5eHOY
default 
default 
defaulthttp://europa.eu/rapid/press-release_IP-13-668_en.htm
default 
default